Cannabis Bioscience International Holdings (CBIH) Non Operating Income (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Non Operating Income came in at -$10675.0 in Q1 2026, up 79.47% year-on-year from -$5947.9 in Q1 2025, and up 49.38% quarter-over-quarter from -$21090.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Non Operating Income (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Non Operating Income across 5 years of filings, most recently posting -$10675.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at -$10675.0, up 79.47% year-over-year; the trailing twelve-month figure through Feb 2026 was -$116470.0 (up 25.77% YoY), and the FY2025 annual result was -$127455.0, up 22.85% from the prior year.
- Non Operating Income came in at -$10675.0 for Q1 2026 at Cannabis Bioscience International Holdings, up from -$21090.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $21299.0 in Q3 2024 to a low of -$106302.0 in Q2 2024.
- The 5-year median for Non Operating Income is -$25503.0 (2023), against an average of -$31049.9.
- Peak annual rise in Non Operating Income reached 525.55% in 2024, while the deepest fall reached 9502.71% in 2024.
- Cannabis Bioscience International Holdings' Non Operating Income stood at -$36278.0 in 2022, then grew by 17.54% to -$29916.0 in 2023, then soared by 33.48% to -$19901.0 in 2024, then fell by 5.97% to -$21090.0 in 2025, then soared by 49.38% to -$10675.0 in 2026.
- The last three Non Operating Income figures came in at -$10675.0 (Q1 2026), -$21090.0 (Q4 2025), and -$7861.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -10,675.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -10,675.00 |
| Nov 30, 2025 | -21,090.00 |
| Aug 31, 2025 | -7,861.00 |
| May 31, 2025 | -76,844.00 |
| Feb 28, 2025 | -52,009.00 |
| Nov 30, 2024 | -19,901.00 |
| Aug 31, 2024 | 21,299.00 |
| May 31, 2024 | -106,302.00 |
| Feb 29, 2024 | -49,221.00 |
| Nov 30, 2023 | -29,916.00 |
| Aug 31, 2023 | -5,005.00 |
| May 31, 2023 | -1,107.00 |
| Feb 28, 2023 | -39,789.00 |
| Nov 30, 2022 | -36,278.00 |